82737-0073 Aphexda - CanMED: NDC

Product NDC:

82737-0073

Brand Name:

Aphexda

Generic Name:

Motixafortide

Dosage Form Name:

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Administration Route:

Subcutaneous

Substances:

Name: MOTIXAFORTIDE ACETATE

Strength: 62.0

Unit: mg/1.7mL

Packages:

Code: 82737-0073-01

Description: 1 VIAL, GLASS in 1 CARTON (82737-073-01) / 1.7 mL in 1 VIAL, GLASS

Effective Date: Sept. 8, 2023

Discontinued:

SEER*Rx Category:

Ancillary Therapy

Major Class:

Immunostimulant

Minor Class:

Stem cell mobilizer

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox